Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...
Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...
(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...
Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.
The International Working Group discussed diagnosing Alzheimer's disease among cognitively unimpaired individuals in a ...
(Reuters) -Cassava Sciences on Monday said its experimental Alzheimer's disease drug did not meet the main or secondary goals ...
Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...
The Alzheimer’s Foundation of America is offering tips to help those traveling with a loved one with a dementia-related ...
Subtle signs of Alzheimer's disease can emerge decades before a diagnosis—often in the form of irregular behaviors that ...
A bill filed Tuesday morning at the Arkansas State Capitol could be a beacon of hope for many with loved ones battling ...
ScienceAlert on MSN22h
Nasal Spray May Slow Alzheimer's Disease, Study in Mice SuggestsThe active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback